H.R. 4764 — 116th Congress
TRANSPLANT Act of 2020
Sponsor
More bills from this sponsor
116th Congress| Measure | Title |
|---|---|
| H.R. 1768 · Environmental Protection | Diesel Emissions Reduction Act of 2019 |
Latest action
Dec 14, 2020Message on Senate action sent to the House.
CRS summary
As of Dec 11, 2020Passed Senate
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020
This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.
Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.
In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.
Congressional Research Service, via api.congress.gov (public domain)
Roll-call votes
1 on recordSep 30, 2020 · On Motion to Suspend the Rules and Pass, as Amended
Full roll callYea — 414: 227 D · 186 R · 1 L
Not Voting — 16: 11 R · 4 D · 1 I
Member pages currently show roll-call votes from the 119th Congress only. The “Member pages” column marks votes from that congress.